Mar 17
|
Ireland’s Profits From Weight-Loss Drugs Draw Trump’s Attention
|
Mar 16
|
Jim Cramer Says: “Keep an Eye on Eli Lilly and Company (LLY)”
|
Mar 16
|
Fix the NHS or miss out on our money, US drug giant warns Britain
|
Mar 15
|
Tesla's problems, Eli Lilly's weight loss pill, and egg prices surge: Business news roundup
|
Mar 15
|
Is Eli Lilly and Company (LLY) the Best Quality Stock to Invest in Now?
|
Mar 14
|
AstraZeneca Stock Scores RS Rating Upgrade
|
Mar 14
|
Eli Lilly (NYSE:LLY) Sees 1.59% Rise As Jaypirca Secures Positive EU Opinion
|
Mar 14
|
Billionaire Ken Griffin More Than Doubled His Stake In This Market-Beating Growth Stock
|
Mar 14
|
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks
|
Mar 14
|
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup
|
Mar 13
|
Eli Lilly (NYSE:LLY) Surges 5% Following Breakthrough BRAVE-AA-PEDS Study Results
|
Mar 13
|
Trump’s $1.4 Trillion Tariff Threat Spurs Companies to Seek Cover
|
Mar 13
|
How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma
|
Mar 12
|
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
|
Mar 12
|
Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion
|
Mar 12
|
Roche, Zealand sign deal: What it means for weight loss drug space
|
Mar 12
|
Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy According to Hedge Funds?
|
Mar 12
|
Novo Nordisk Is Falling. Competition Is a Killer.
|
Mar 12
|
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
|
Mar 3
|
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
|